As of today, ASAPS does not have explicit and legally binding instructions from the regulatory authorities, to endorse return to non-surgical cosmetic injecting.
ASAPS cannot, at this time, recommend resuming treatments using neurotoxins and tissue fillers for cosmetic indications until further information is forthcoming. ASAPS acknowledges that this situation is fluid and subject to change.
ASAPS has prioritised public and patient safety over and above everything else and are greatly appreciative of the Government’s efforts during this unprecedented pandemic and are supportive of all measures.
This message supersedes advice given to ASAPS members on 24 April 2020.